Considerations for Drug Interactions on QTc in Exploratory COVID-19 Treatment

被引：114
作者：
Roden, Dan M. [1 ]
Harrington, Robert A. [2 ]
Poppas, Athena [3 ]
Russo, Andrea M. [4 ,5 ]
机构：
[1] Vanderbilt Univ, Sch Med, Div Cardiovasc Med & Clin Pharmacol, Nashville, TN 37232 USA
[2] Stanford Univ, Dept Med, Stanford, CA 94305 USA
[3] Brown Univ, Sch Med, Cardiol Div, Providence, RI 02912 USA
[4] Cooper Univ Hosp, Electrophysiol & Arrhythmia Serv, Camden, NJ USA
[5] Rowan Univ, Cooper Med Sch, Clin Cardiac Electrophysiol Fellowship Program, Camden, NJ USA
来源：
CIRCULATION | 2020年 / 141卷 / 24期
关键词：
arrhythmias; cardiac; COVID-19; drug effects; drug-related side effects and adverse reactions; severe acute respiratory syndrome coronavirus 2; INTERVAL PROLONGATION; AZITHROMYCIN; RISKS;
D O I：
10.1161/CIRCULATIONAHA.120.047521
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：E906 / E907
页数：2
相关论文
共 50 条
[41]   Drug-Drug Interactions among Patients Hospitalized with COVID-19 in Greece [J].
Spanakis, Marios ;
Ioannou, Petros ;
Tzalis, Sotiris ;
Papakosta, Vasiliki ;
Patelarou, Evridiki ;
Tzanakis, Nikos ;
Patelarou, Athina ;
Kofteridis, Diamantis P. P. .
JOURNAL OF CLINICAL MEDICINE, 2022, 11 (23)
[42]   Drug-drug interactions between COVID-19 therapeutics and psychotropic medications [J].
Cuomo, Alessandro ;
Barilla, Giovanni ;
Serafini, Gianluca ;
Aguglia, Andrea ;
Amerio, Andrea ;
Cattolico, Matteo ;
Carmellini, Pietro ;
Spiti, Alessandro ;
Fagiolini, Andrea .
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2023, 19 (12) :925-936
[43]   Combination of Hydroxychloroquine Plus Azithromycin As Potential Treatment for COVID-19 Patients: Safety Profile, Drug Interactions, and Management of Toxicity [J].
Hache, Guillaume ;
Rolain, Jean Marc ;
Gautret, Philippe ;
Deharo, Jean-Claude ;
Brouqui, Philippe ;
Raoult, Didier ;
Honore, Stephane .
MICROBIAL DRUG RESISTANCE, 2021, 27 (03) :281-290
[44]   Multidrug treatment for COVID-19 [J].
Ohe, Masashi ;
Furuya, Ken ;
Goudarzi, Houman .
DRUG DISCOVERIES AND THERAPEUTICS, 2021, 15 (01) :39-41
[45]   Antiviral Drug Discovery for the Treatment of COVID-19 Infections [J].
Ng, Teresa, I ;
Correia, Ivan ;
Seagal, Jane ;
DeGoey, David A. ;
Schrimpf, Michael R. ;
Hardee, David J. ;
Noey, Elizabeth L. ;
Kati, Warren M. .
VIRUSES-BASEL, 2022, 14 (05)
[46]   Drug repositioning is an alternative for the treatment of coronavirus COVID-19 [J].
Serafin, Marissa B. ;
Bottega, Angelita ;
Foletto, Vitoria S. ;
da Rosa, Tacieli F. ;
Horner, Andreas ;
Horner, Rosmari .
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2020, 55 (06)
[47]   Emergent Drug and Nutrition Interactions in COVID-19: A Comprehensive Narrative Review [J].
Agagunduz, Duygu ;
Celik, Mensure Nur ;
Citar Daziroglu, Merve Esra ;
Capasso, Raffaele .
NUTRIENTS, 2021, 13 (05)
[48]   The Potential Drug Interactions Between Multiple Sclerosis and COVID-19 Therapies [J].
Goncuoglu, Cansu ;
Bayraktar Ekincioglu, Aygin ;
Tuncer, Asli .
TURKISH JOURNAL OF PHARMACEUTICAL SCIENCES, 2021, 18 (06) :665-666
[49]   Evaluation of potential drug-drug interactions and polypharmacy in hospitalized COVID-19 patients [J].
Kilit, Turkan Pasali ;
Ozyigit, Filiz ;
Erarslan, Sertas ;
Onbasi, Kevser .
AFRICAN HEALTH SCIENCES, 2022, 22 (04) :597-606
[50]   Efficacy, Safety, and Drug-Drug Interactions for Insomnia Therapy in COVID-19 Patients [J].
Saputra, Billy Dwi ;
Levita, Jutti ;
Mustarichie, Resmi .
JOURNAL OF MULTIDISCIPLINARY HEALTHCARE, 2022, 15 :137-152
12345